Prime Capital Investment Advisors’s Boston Scientific BSX Stock Holding History

Prime Capital Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$317K	Sell	7,422 -2,756	-27%	-$150K	﹤0.01%	843
2026 Q1	$639K	Sell	10,178 -697	-6%	-$55.8K	0.01%	611
2025 Q4	$1.04M	Sell	10,875 -325	-3%	-$31.9K	0.01%	491
2025 Q3	$1.09M	Buy	11,200 +234	+2%	+$24.2K	0.01%	464
2025 Q2	$1.18M	Sell	10,966 -1,885	-15%	-$191K	0.02%	435
2025 Q1	$1.3M	Buy	12,851 +2,891	+29%	+$291K	0.02%	449
2024 Q4	$890K	Sell	9,960 -96	-1%	-$8.45K	0.01%	446
2024 Q3	$843K	Buy	10,056 +1,638	+19%	+$129K	0.01%	474
2024 Q2	$648K	Sell	8,418 -610	-7%	-$44.6K	0.01%	518
2024 Q1	$618K	Sell	9,028 -956	-10%	-$61.5K	0.01%	567
2023 Q4	$577K	Buy	+9,984	New	+$533K	0.01%	544

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Prime Capital Investment Advisors's BSX Position: Q2 2026 in Review

Prime Capital Investment Advisors reduced its Boston Scientific (BSX) stake by 27% in Q2 2026, selling an estimated $150K and leaving 7,422 shares worth $317K. The position accounts for ﹤0.01% of the portfolio, ranked #843.

Prime Capital Investment Advisors first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.3M in Q1 2025. 1,052 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Prime Capital Investment Advisors held 7,422 shares of Boston Scientific worth $317K as of Q2 2026.
Prime Capital Investment Advisors sold 2,756 Boston Scientific shares in Q2 2026, an estimated $150K.
Boston Scientific made up ﹤0.01% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #843 holding.
Prime Capital Investment Advisors first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
Prime Capital Investment Advisors's Boston Scientific position peaked at $1.3M in Q1 2025.
1,052 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.